Teams

Sector
Stage
  • ARTS Surgical Inc.
    from University of Texas at Austin.

    Our solution is a state of the art steerable drilling technology and a novel implant  featuring advanced precision to ensure higher accuracy in complex orthopedics and neurosurgical procedures and improve patient outcomes.

    Read More
  • GeneVentiv Therapeutics, Inc.
    from University of North Carolina at Chapel Hill.

    GeneVentiv's AAV8.FVa gene therapy is the first universal gene therapy for all hemophilias and the first to treat inhibitor patients.

    Read More
  • Lumaegis, Inc
    from University of Texas at Austin.

    We help dentists and medical professionals sterilize equipment in a few minutes instead of an hour using special light instead of wasting water. An average dentist saves $100,000 and 2 million gallons of water each year.

    Read More
  • OrthoPreserve, Inc.
    from Georgia Institute of Technology.

    OrthoPreserve is developing a minimally invasive meniscus implant to relieve pain, restore mobility, and reduce the risk of knee joint arthritis for patients.

    Read More